Posted April 10, 2016
Compass Concludes full Exit for Raya and Sphinx in Rameda Pharmaceuticals
Full exit of the investors’ c.45% in Rameda Pharmaceutical after 5 years since acquisition, underscoring its ability to transform businesses and create value for partners